Clinical Trial

Fostering Prosocial Preventive Behaviours Through Awe

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated March 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized control trial is to investigate the impact pf awe on prosocial preventive behaviours against infectious diseases among adults from Hong Kong, Singapore, and ten major cities in Mainland China (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Chongqing, Chengdu, Wuhan, Xi'an, Nanjing). The main questions it aims to answer are: * Does experiencing awe increase adults' intentions to engage in prosocial preventive behaviours against infectious diseases, including vaccination, mask wearing, and social distancing? * Does the impact vary across three research sites?
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-05.
Trial Details
NCT Number NCT07406529
Lead Sponsor The University of Hong Kong
Conditions Infectious Diseases
Enrollment 456 participants
Start Date 2025-10-27
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-27